The ACR adopted its "Guideline for Communication: Diagnostic Radiology" in 1991. Since its adoption, the guideline has been the subject of considerable discussion and controversy. In response to more than a decade of debate, the ACR appointed a task force in the summer of 2003 to research and analyze claims and litigation decisions that have been related to the communication or reporting of imaging studies by radiologists. Furthermore, the task force was charged with making recommendations regarding the status and impact of the existing communication guideline. The only specific directions to the task force were to take into account the ACR's motto, "Quality is our image," in the recognition that communication plays an essential role in safety and quality. The task force consulted outside legal counsel, reviewed claims data from many sources, and performed a survey of the ACR's membership. Furthermore, the task force was divided into four working groups to focus on the data and make specific recommendations. The products of the working groups were assembled into a final report that was presented to the ACR Board of Chancellors in the winter of 2004. This report, including five recommendations, and a draft for a new communication guideline were presented to the ACR Council at the annual meeting in May 2004.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jacr.2004.08.005 | DOI Listing |
ERJ Open Res
January 2025
Department of Otolaryngology-Head and Neck Surgery, University of California, Los Angeles, Los Angeles, CA, USA.
Background: Chronic rhinosinusitis (CRS) and olfactory dysfunction (OD) are prevalent disease complications in people with cystic fibrosis. These understudied comorbidities significantly impact quality of life. The impact of highly effective modulator therapy (HEMT) in young children with cystic fibrosis (YCwCF) on these disease complications is unknown.
View Article and Find Full Text PDFResusc Plus
January 2025
Emergency Medical Services, Capital Region of Denmark, Ballerup, Denmark.
Unlabelled: Out-of-hospital cardiac arrest (OHCA) remains a critical health concern, where prompt access to automated external defibrillators (AEDs) significantly improves survival. This scoping review broadly investigates the feasibility and impact of dronedelivered AEDs for OHCA response.
Methods: PubMed, Cochrane, and Web of Science were searched from inception to August 6, 2024, with eligibility broadly including empirical data.
J Clin Nurs
January 2025
Department of Psychosomatic Medicine and Psychotherapy, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.
Background: Health care workers (HCW) with post-COVID condition (PCC) are frequently reported to suffer from mental health impairment. Given HCW above-average risk for mental health, research is necessary and risk factors need to be assessed.
Aim: To compare mental health and health of German HCW with and without PCC and to identify associated psychological and social factors.
Neuroscience
January 2025
Department of Orofacial Pain and Jaw Function, Malmö University, Malmö, Sweden; Scandinavian Center for Orofacial Neurosciences (SCON), Aarhus, Denmark; Scandinavian Center for Orofacial Neurosciences (SCON), Malmö, Sweden.
Occlusal tactile acuity (OTA) and bite force are essential components of the sensorimotor control of oral behaviors. While these variables have been studied independently, it has not yet been revealed whether compressive force impacts the occlusal perception mediated by the mechanoreceptive afferents in the periodontal ligament. The present study examined the effect of repetition and maximum bite force on OTA by testing nine aluminum foils of different thicknesses together with a sham test with no foil, three times each, in randomized order in 36 healthy individuals.
View Article and Find Full Text PDFMaturitas
November 2024
Hormone Hamburg, Hamburg, Germany. Electronic address:
Objective: To report patient-reported quality-of-life (QOL) outcomes in the DAYLIGHT study.
Study Design: DAYLIGHT was a phase 3b, randomized, double-blind, 24-week, placebo-controlled study. Participants were women aged ≥40 to ≤65 years with moderate to severe vasomotor symptoms (VMS) considered unsuitable for hormone therapy (HT) (contraindications, caution, stoppers, or averse) randomized 1:1 to placebo or fezolinetant 45 mg once daily.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!